Skip to main content

Table 5 Biomarkers at admission among patients with falciparum malaria and healthy individuals

From: The predictive capacity of biomarkers for clinical pulmonary oedema in patients with severe falciparum malaria is low: a prospective observational study

Variables

n

Severe malaria

n

Uncomplicated malaria (n = 50)

n

Healthy individuals (n = 16)

P valuea

Non-CPE patients (n = 45)

n

CPE patientsb (n = 9)

n

Allc (n = 56)

IL-6, pg/mL

45

192 [89 to 521]

9

287 [77 to 767]

56

193 [87 to 732]

50

53 [15 to 148]

16

2 [2 to 3]

0.880

IL-8, pg/mL

45

65 [32 to 107]

9

190 [60 to 282]

56

66 [31 to 172]

48

23 [13 to 47]

11

10 [6 to 12]

0.232

TNF, pg/mL

45

144 [70 to 222]

9

135 [86 to 241]

56

140 [71 to 245]

49

54 [27 to 77]

11

7 [4 to 30]

0.736

RAGE, pg/mL

45

4312 [2744 to 7509]

9

4569 [3330 to 6496]

56

4514 [2744 to 7345]

50

2603 [2180 to 3332]

16

2585 [2168 to 3149]

0.991

SP-D, pg/mL

45

3323 [962 to 5644]

9

2766 [1478 to 6129]

56

3252 [1313 to 5971]

48

2865 [1427 to 6900]

16

7321 [5740 to 9934]

0.790

CC-16, pg/mL

45

11,299 [7266 to 21128]

9

8796 [7133 to 26947]

56

11,471 [7233 to 21572]

50

6460 [3720 to 10081]

16

12,289 [9445 to 15698]

0.790

KL-6, U/mL

45

17 [10 to 25]

8

21 [14 to 47]

55

18 [10 to 28]

49

18 [12 to 23]

16

24 [17 to 29]

0.253

  1. All data as median [IQR]
  2. The number of patients (n) in each group are 45, 9, 56, 50, and 16, respectively, except where indicated
  3. CPE clinical pulmonary oedema, IL-6 interleukin-6, IL-8 interleukin-8, TNF tumour necrosing factor, sRAGE soluble receptor of advanced glycation end-products, SP-D surfactant protein D, CC16 club cell secretory protein, KL-6 Krebs von den Lungen 6
  4. aFor comparison between non-CPE patients vs. CPE patients with severe malaria
  5. bThis group includes patients with severe malaria who developed clinical pulmonary oedema after admission. Two patients who had clinical pulmonary oedema on admission are not included in this group
  6. cThis group includes two patients who had clinical pulmonary oedema on admission